candesartan cilexetil has been researched along with Precordial Catch in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| "from a total of 112 treatment-naive patients and 381 previously treated patients eligible for safety analysis, there were only 3 patients with adverse events, and 2 of which were considered possibly related to candesartan (0." | 1.39 | Safety and effectiveness of candesartan and candesartan/HCT fixed dose combination in patients with hypertension. ( Pohan, T; Setiawati, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Setiawati, A | 1 |
| Pohan, T | 1 |
1 other study available for candesartan cilexetil and Precordial Catch
| Article | Year |
|---|---|
Safety and effectiveness of candesartan and candesartan/HCT fixed dose combination in patients with hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Chest Pain; Diuretics; Dru | 2013 |